The latest on COVID-19 and vaccines: Johnson & Johnson shots continue to be on pause as health officials investigate extremely rare side effects; Moderna and Pfizer vaccination appointments are becoming easier to snag in many states; and what scientists are…
By PBS NewsHour
The U.S. lags in testing coronavirus samples from COVID-19 patients, which can help track the spread of the virus and the emergence of new variants. But labs are ramping up this crucial surveillance.
By Alexander Sundermann, Lee Harrison, Vaughn Cooper, The Conversation
As the U.S. vaccinates millions more people each day, the novel coronavirus works to survive. It does this by mutating. So far, several variants are worrisome. A virologist explains what they are.
By Paulo Verardi, The Conversation
The safest way to approach socializing in an ongoing pandemic involves a similar risk assessment to the one many people have been exercising since stay-at-home orders were lifted months ago, rather than throwing caution to the wind.
By Isabella Isaacs-Thomas
By Christina Jewett, JoNel Aleccia, Rachana Pradhan, Kaiser Health News
As experts race to get an approved test for COVID variants, officials are severely restricted from sharing information about the cases. That makes it harder to protect others.
By Laura Santhanam
Drugmakers are exploring how to tailor vaccines more narrowly to these mutants, but modifying existing vaccines is not as easy as flipping a switch.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.